Edition:
India

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

6.12USD
20 Apr 2018
Change (% chg)

$-0.07 (-1.13%)
Prev Close
$6.19
Open
$6.18
Day's High
$6.18
Day's Low
$6.08
Volume
5,835
Avg. Vol
54,681
52-wk High
$15.78
52-wk Low
$4.42

Chart for

About

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely... (more)

Overall

Beta: 1.92
Market Cap(Mil.): $14.39
Shares Outstanding(Mil.): 28.24
Dividend: --
Yield (%): --

Financials

BRIEF-Tenax Therapeutics Announces Plan To Develop Levosimendan For A Pulmonary Hypertension Indication With No FDA Approved Therapies

* TENAX THERAPEUTICS ANNOUNCES PLAN TO DEVELOP LEVOSIMENDAN FOR A PULMONARY HYPERTENSION INDICATION WITH NO FDA APPROVED THERAPIES

16 Jan 2018

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF76.08 -1.20
Merck & Co., Inc. (MRK.N) $58.83 +0.19
Roche Holding Ltd. (ROG.S) CHF215.65 -0.85
Roche Holding Ltd. (RO.S) CHF220.00 -0.20
Abbott Laboratories (ABT.N) $59.19 -0.69
Bayer AG (BAYGn.DE) €99.00 -0.60
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €65.28 -0.32
Eli Lilly And Co (LLY.N) $79.06 -0.69
Bristol-Myers Squibb Co (BMY.N) $51.17 -0.44

Earnings vs. Estimates